Conclusions GLP-1RAs are highly effective medications for treating obesity and its complications, and emerging research suggests they may also be promising for managing other medical conditions
Therefore, it is logical to suggest that synaptic dysfunctions occur in individuals with SLOS
The use of GHK-Cu has not been established in pediatric, pregnant, and breastfeeding individuals
The prodrug design of Vyvanse does not eliminate abuse risk (it is still Schedule II), but the blunted pharmacokinetic curve may reduce the reinforcing euphoria that drives recreational use
HUBERMAN: Now, of course, I strive to consume healthy whole foods for the majority of my nutritional intake every single day, but there are a number of things in AG1, including specific micronutrients, that are hard to get from whole foods, or at least in sufficient quantities